Prediction of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer via Early Changes in Tumor Heterogeneity Captured by DCE-MRI Registration
Abstract We analyzed DCE-MR images from 132 women with locally advanced breast cancer from the I-SPY1 trial to evaluate changes of intra-tumor heterogeneity for augmenting early prediction of pathologic complete response (pCR) and recurrence-free survival (RFS) after neoadjuvant chemotherapy (NAC)....
Guardado en:
Autores principales: | Nariman Jahani, Eric Cohen, Meng-Kang Hsieh, Susan P. Weinstein, Lauren Pantalone, Nola Hylton, David Newitt, Christos Davatzikos, Despina Kontos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0601eed831a34a94ace4834b105c119b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MRI enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy.
por: Ella F Jones, et al.
Publicado: (2013) -
Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs
por: Maria Colomba Comes, et al.
Publicado: (2021) -
Radiomics Analysis of Multi-Phase DCE-MRI in Predicting Tumor Response to Neoadjuvant Therapy in Breast Cancer
por: Shuyi Peng, et al.
Publicado: (2021) -
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
por: Mark Jesus M. Magbanua, et al.
Publicado: (2021) -
Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC
por: Ye Chengyu, et al.
Publicado: (2021)